Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

D-Histidine

    • Product Name D-Histidine
    • Alias His
    • Einecs 214-934-6
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    828173

    Product Name D-Histidine
    Cas Number 774-26-9
    Molecular Formula C6H9N3O2
    Molecular Weight 155.16
    Appearance White to off-white crystalline powder
    Melting Point 279-284°C (dec.)
    Solubility In Water Soluble
    Optical Rotation [α]D20 ≈ -53° (c=1, H2O)
    Purity ≥98%
    Storage Temperature 2-8°C

    As an accredited D-Histidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing D-Histidine, 25g, is packaged in a sealed, amber glass bottle with a screw cap, labeled with handling and safety information.
    Shipping D-Histidine is typically shipped in tightly sealed containers to protect it from moisture and contaminants. During transport, it is stored at room temperature or as specified by the manufacturer, and packed according to chemical safety regulations. Documentation includes handling instructions, hazard identification, and compliance with local and international shipping guidelines.
    Storage D-Histidine should be stored in a tightly sealed container, protected from light and moisture. Keep it at a cool, dry place, ideally at 2-8°C (refrigerator). Avoid exposure to heat and incompatible substances. Label clearly and handle in accordance with standard laboratory safety protocols. Store away from oxidizing agents and strong acids to ensure chemical stability and safety.
    Application of D-Histidine

    Applications of D-Histidine in Industrial Manufacturing

    D-Histidine, supplied with stringent quality control from our factory, serves targeted roles in specialized downstream sectors. The following sections detail real-world industrial applications, including regulatory standards, dose parameters, process positions, and finished product types unique to each scenario. All information derives from genuine customer usage and sector-specific compliance requirements.

    1. Peptide Synthesis for Pharmaceutical Intermediates

    Peptide synthesis facilities use D-histidine to incorporate this chiral amino acid into the assembly of complex peptide APIs and pharmaceutical intermediates, particularly for compounds where D-configuration residues enhance bioactivity or metabolic stability. D-histidine enters the automated or semi-automated solid-phase or solution-phase synthesis process, functioning as a building block for peptides requiring strict isomeric purity and traceable raw material origin for regulatory filings. Its role is most prominent where the end-use peptide targets therapeutic classes such as antimicrobial, anticancer, and enzyme-inhibitory molecules.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • European Pharmacopoeia (Ph. Eur.) standards for amino acid starting materials
    • USP-NF requirements for peptide components
    • FDA 21 CFR Part 210/211 for pharmaceutical manufacturing

    Typical usage ratio

    • 0.5–3 mol% relative to total amino acid content in the peptide; precise dosage depends on peptide structure and D-residue positioning

    Downstream process integration

    • Directly charged to the amino acid activation and coupling stage within automated peptide synthesizers or batch reactors
    • Controlled weighing and dispensing via validated equipment to ensure batch traceability
    • Batch records consistently document D-histidine lot traceability for regulatory audit trails

    Final product types

    • Synthetic therapeutic peptides (API intermediates for injectables, oral drugs)
    • Peptide reference standards for bioanalytical laboratories
    • Custom peptide research reagents

    2. Cell Culture and Bioprocessing Media Formulation

    Biomanufacturing facilities employ D-histidine as a non-proteinogenic medium component in specific mammalian and microbial cell culture media. It functions as a selective growth regulator or as part of defined selection systems in strain engineering (auxotrophy protocols), especially during the development or propagation of genetically engineered cell lines using selective markers. Precise addition and documentation are required for regulatory filing and reproducibility of culture conditions in the production of biologicals such as recombinant proteins and monoclonal antibodies.

    Industry compliance standards

    • ISO 13408 for aseptic processing of health care products
    • USP <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products
    • FDA Points to Consider for Cell Culture Media Components Used in Manufacturing of Biological Drugs
    • cGMP for Biologics (21 CFR 600-680)

    Typical usage ratio

    • Ranging from 0.01–0.1 g/L, customized based on cell line sensitivity and selection protocol; adjusted via media optimization runs

    Downstream process integration

    • Added at media blending through sterile filtration or during post-sterilization supplementation for trace element stability
    • Ingredient batch records logged for every production and development lot
    • Quality teams monitor lot-to-lot consistency with each delivery

    Final product types

    • Recombinant protein therapeutics
    • Monoclonal antibody drugs
    • Cell therapy intermediates and master cell banks

    3. Diagnostic Kit and Enzyme Substrate Production

    Manufacturers of biochemical diagnostic kits and enzyme substrate reagents incorporate D-histidine for enzyme activity differentiation and stereoselectivity analysis. D-histidine acts as a substrate or selective inhibitor in diagnostic assays that distinguish between enantiomeric forms of histidine, applied in both clinical and research settings. Maintaining substrate integrity and concentration fidelity is essential for kit lot qualification and the reproducibility of diagnostic outcomes as required by healthcare regulations.

    Industry compliance standards

    • ISO 13485 for medical device and diagnostic kit manufacturing
    • CLSI guidelines for in vitro diagnostic reagent validation
    • EU IVDR (In Vitro Diagnostic Regulation) for CE-marked test kits
    • 21 CFR Part 820 (FDA QSR) for quality system regulation

    Typical usage ratio

    • 0.01–1 mM concentration in assay buffers or substrate solutions, depending on enzyme substrate kinetics and specificity requirements of the detection platform

    Downstream process integration

    • Blended at reagent formulation mixing step, pre-aliquoted into lyophilized or liquid format vials depending on kit design
    • QC tested for enantiomeric purity and stability prior to lot release

    Final product types

    • Amino acid analyzer calibration kits
    • Diagnostic enzyme activity test kits (as controls or substrates)
    • Chromogenic assay components for clinical laboratory use

    4. Specialized Food Additives for Nutritional Formulations

    Nutrition and health product manufacturers, operating in highly regulated regions, use D-histidine in scientifically justified applications such as metabolic research foods or special medical dietary supplements. Though not permitted in general foodstuffs, D-histidine plays a role in dietetic products for studies involving amino acid metabolism or to meet rare metabolic requirements under medical supervision, always requiring strict adherence to local food safety and additive regulations.

    Industry compliance standards

    • Codex Alimentarius food additive guidelines (where applicable)
    • EU Regulation (EC) No 1333/2008 on food additives
    • FDA 21 CFR 172 for food additives permitted for direct addition to food for human consumption (subject to GRAS evaluations and limitation to research or supervised medical foods)
    • ISO 22000 Food Safety Management Systems

    Typical usage ratio

    • 0.01–0.1% w/w in blended medical nutrition; actual level defined by clinical research protocol and product safety risk assessment

    Downstream process integration

    • Dry mixed with base protein or carbohydrate matrix before granulation or tableting in precision-controlled clean rooms
    • Documentation and release testing required for each batch to comply with food safety risk management

    Final product types

    • Amino-acid modified foods for special medical purposes (FSMP)
    • Research-use nutrition blends
    • Medical food tablets and powders

    5. Chirality Reference Standard Preparation for Analytical Laboratories

    Certified laboratories preparing analytical chiral standards use D-histidine as a calibration molecule for chromatographic methods, including HPLC and capillary electrophoresis. The standard ensures accuracy and repeatability when quantifying D/L-ratio in pharmaceutical R&D, food authentication, or chemical QC. The rationale for using D-histidine is its well-defined stereochemistry and commercial availability in high purity, which is essential for method validation and instrument calibration protocols in regulated settings.

    Industry compliance standards

    • ISO/IEC 17025 for laboratory calibration and testing quality
    • USP General Chapters <621>, <781> for chromatographic system suitability
    • GLP (Good Laboratory Practice) for test and calibration
    • European Pharmacopoeia requirements for reference standards

    Typical usage ratio

    • Standard solution preparations range from 0.1–10 mM, depending on detection linearity and matrix effects for target method validation

    Downstream process integration

    • Dissolved in precise volumetric flasks, filtered, and dispensed into vials for use as stand-alone chiral markers or in mixed reference solutions
    • Lot documentation and certificate of analysis accompany each standard batch

    Final product types

    • Chiral calibration standards for HPLC or CE
    • Analytical reference solutions for D/L-amino acid quantitation
    • System suitability test kits for pharmaceutical and food labs
    Free Quote

    Competitive D-Histidine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    D-Histidine: Dependable Performance for Specialized Applications

    Commitment to Quality from the Manufacturer’s Bench

    Producing D-Histidine on an industrial scale takes steady focus and a dose of patience. Our team in the synthesis facility knows this compound up close. Each lot reflects a decade refining the crystallization and purification steps necessary to meet the strict benchmarks for chiral amino acids. Over time, we have gained an understanding of what reliable D-Histidine means for our clients who run research and production lines alike.

    We offer D-Histidine as a white crystalline powder, matching the molecular formula C6H9N3O2, with a molecular weight of 155.16 g/mol. Optical purity is not just a number here; every batch leaves our plant with a minimum enantiomeric excess of 98%. Moisture and residual solvent content fall well under industry thresholds because unchecked impurities can alter outcomes, especially where D-Histidine functions as a starting material for more sensitive synthesis steps or enzyme kinetics assays. Each drum and every jar we ship belongs to an uninterrupted production trace, so source transparency means users always know exactly what goes into their downstream processes.

    Where D-Histidine Fits In: Applications Based on Experience

    D-Histidine never shows up where L-Histidine’s role is crucial, but its technical strengths begin to shine in peptide research and select enzyme work. We have worked with peptide chemists designing new therapeutic scaffolds. Their efforts revolve around the unique geometry of D-amino acids, which can increase peptide stability against enzymatic breakdown. The isomeric purity we deliver has mattered for both synthesis yield and predicting biological responses during development runs.

    In some fermentation settings, D-Histidine is introduced to test pathways that discriminate against biologically active L-forms. Protein engineers use it to probe mechanisms of racemase and epimerase enzymes. Academic customers report that our batches help establish clear controls in studies on chiral discrimination and enzyme selectivity. For these research settings, the lack of cross-contamination saves weeks that might have been lost to troubleshooting unexplained peaks in NMR or HPLC.

    Industrial clients with interests in crop science and veterinary projects sometimes use D-Histidine to block or monitor specific biosynthetic chains. Animal feed researchers can benefit from having access to pure D-Histidine in dietary control studies for non-standard metabolic models. These projects depend on reliable supply, steady quality, and the ability to trace batches back to methodically kept batch records.

    Distinguishing D-Histidine from the L-Form and Racemates

    One of the most frequent questions that comes our way is about what sets D-Histidine apart from the more widely used L-enantiomer. By training and daily work, we pay attention to those differences, both in manufacture and in use. The L-form fits directly into human and animal metabolic pathways and is essential for protein synthesis. D-Histidine, as a mirror image, resists most naturally occurring enzymes, so it proves valuable in research settings where the goal is to slow or modify biological reactions.

    In our plant, keeping D-Histidine separate avoids accidental racemization and ensures true single-enantiomer supply. There is no cross-over of raw materials or equipment between runs of D- and L-forms. This may not matter to a casual observer, but enzyme selectivity and biological testing can become unpredictable with even trace racemization. We monitor for this at several steps, using optical rotation and chiral HPLC, because chemists and biologists who depend on true D-forms for their studies simply cannot afford shortcuts.

    In some commercial contexts, racemic histidine is available, usually produced via non-chiral synthesis routes for applications that do not need pure stereochemistry. We avoid these routes in our D-Histidine production to preserve clarity of results for users conducting analytical testing or building peptide drugs with known biological properties.

    Formulation and Specifications: Why Experience Matters

    Direct feedback from customers drives our specifications. Laboratories testing new catalysts were among the first to tell us straight how trace metals or organic impurities skewed their findings. Establishing the need for low heavy metal and residual solvent content in every lot of D-Histidine has involved performing repeated ICP-MS profiles and adopting solvent-purging steps that many traders simply overlook. We rarely encounter inquiries about strange solvent spikes or odd coloration. Instead, we hear from customers who manage multi-month projects with consistent materials and ask for certificates matching regulator expectations.

    Moisture is often the overlooked parameter in amino acid manufacturing, so we seal and test our product following drying. This prevents clumping and false readings in weight-critical applications. A shelf life measured in years comes from years learning how to package D-Histidine with desiccants and barrier liners. Even when large volumes ship overseas, crystallinity and ease of handling persist until the last gram. We maintain regular communication with staff at client sites about storage, packaging customization, and shipment tracing, without pushing complex technical language or making claims outside our direct production chain.

    Reliability and Transparency as Foundations

    Procurement teams and project leads have enough to worry about with volatile pricing and changing international regulations. By streamlining batch documentation, we give direct access to lot-specific records. Some clients request validation samples for method development, and we provide them directly from the active production lines. All analytical data tie back to the day-to-day records of synthesis, filtration, and packaging. No off-the-shelf blending, no untraceable reprocessing.

    Because we synthesize D-Histidine on-site, we keep enough capacity to manage both scheduled orders and sudden surges. This adaptability stems from years spent adjusting batch sizes and order lead times to our clients’ cyclical needs in academia, biotech, and industry. Remote facilities sometimes ask for specialized container sizes; our packaging lines stand ready to fill orders from several hundred grams up to drum-scale without pausing main production flows.

    Supporting R&D: Beyond Generic Reagents

    Research and pilot-scale projects often demand greater accountability than large volume commodity chemicals. One development group at a drug discovery firm needed D-Histidine to fine-tune their library of peptidomimetics. Their screening assays highlighted minute differences in purity between competing sources. Direct collaboration led us to adjust our drying process, resulting in improved solubility and easier sample weighing for them, with little change to our overall workflow. Small adaptations like these continue to guide how our technical team approaches the needs of newer fields such as peptide macrocyclization, chiral probe design, and next-generation fermentation platforms.

    In university labs, postdocs send us lists of questions about trace component profiles and residual solvents. We see this as part of the job: if you can’t back up performance with clear data and practical experience, your product isn’t standing on solid ground. Our production chemists respond directly to inquiries with hard data, not just templated answers.

    Continual Improvement: Hearing from the End-Users

    We recognize that market demand evolves faster than most manufacturing cycles. After each contract, we ask customers—whether PhD project supervisors or commercial combinatorial chemistry teams—what we can improve. Some want smaller aliquots for quick-access storage, others ask for more comprehensive impurity profiles, and a handful want to coordinate shipment directly to their site’s cold chain. This input finds its way back to our batching, logistics, and technical support teams.

    Last year, a customer in agricultural research wanted us to test for a list of new contaminants relevant to their soil analysis work. We incorporated new control points in our analytical workflow, which now provide more robust data to others in related fields. This feedback loop sharpens our ability to supply not just D-Histidine as a chemical, but as a reliable research partner.

    Confronting Challenges Specific to D-Histidine Manufacture

    Chiral discrimination in synthesis becomes a challenge the minute volumes need to scale beyond a few hundred grams. Resolution processes can leave contaminants, and any shortcut risks degrading not just the batch, but the integrity of a client’s research. We have invested in monitored cooling, filtration, and crystallization systems that prevent partial racemization. Each subsystem receives regular verification runs, and maintenance crews keep clear records that help spot small fluctuations before they become big problems.

    Maintaining an uninterrupted supply chain for pure D-Histidine also means holding stock of key raw materials under environment-controlled conditions. Market instability can choke off some sources of starting reagents. By building long-term relationships with primary producers and running periodic quality verifications, we have kept raw material quality steady even as global dynamics shift. Clients who have faced forced substitutions elsewhere tell us how a transparent supplier saves months of investigation and repeated method development.

    Our logistics and compliance teams keep detailed records and monitor destination market regulations for both chemical and documentation requirements. Shipments intended for research markets in North America, Europe, and parts of Asia leave our facility with paperwork reflecting the actual analytical data, not blanket declarations or third-party summaries. This baseline transparency supports audits and repeat procurement requests for organizations that require annotated product histories.

    Addressing the Drawbacks of Poor-Quality Supply

    Few things hinder research progress faster than off-spec material. We have had conversations with R&D teams that spent weeks troubleshooting analytical artifacts, only to find a contaminant in their reagent was the root cause. By integrating a process for pre-shipment QC testing, we cut down on batch-to-batch surprises. Clients receive detailed COAs that reflect both technical and practical benchmarks. If an issue surfaces post-delivery, real people with production experience step in and review batch records, so investigation turns into action rather than back-and-forth emails.

    We do not outsource D-Histidine production, so our technical staff remain involved right up to shipment. Problems or requested modifications do not get redirected to unknown facilities or traders. This proves important for research-heavy customers, some of whom need modifications to standard purity, particle size, or drying profile, especially as project timelines tighten and regulatory scrutiny grows.

    Sustainable Manufacturing Choices

    Environmental stewardship sits close to home for manufacturers who manage persistent solvents and byproducts in the amino acid sector. As front-line operators, we work to minimize chemical waste and recover solvents from each step of D-Histidine synthesis. Our water systems operate in closed loops, and solid residues move into verified disposal streams. Clients increasingly request updates on how their supply choices align with their own sustainability targets, prompting us to further document and publish our process improvements.

    Packaging materials are chosen based on both chemical compatibility and lifecycle impacts. Whenever feasible, we opt for recyclable drum liners and shipping cartons, with batch-level tracking for each delivery. End-users with environmental compliance requirements receive documents reflecting not just material safety, but evidence of minimized recovery waste, energy-efficient filtration, and solvent recycling.

    Comparison with L-Histidine and Other Amino Acid Products

    D-Histidine resists the enzymatic machinery found in most living systems, standing apart from its L-form sibling. In the food and pharmaceutical sectors, only the L-form receives attention for supplementation or therapeutic uses. D-Histidine’s distinct value centers on model systems, analytical controls, and chiral drug building. Most standard L-form batches from commodity suppliers do not undergo chiral purity verification, which can leave gaps at the cutting edge of academic and biotech work.

    We do not produce D-Histidine as a racemate. Blends or unpurified stocks simply do not deliver the required predictability for controlled studies. For customers whose work straddles both D- and L-enantiomer spaces, we provide detailed process histories so researchers can fully document the provenance and specs of each compound applied. The differences in handling, supply traceability, and contamination risks run deeper than basic molecular formulae.

    Looking Ahead: New Demands, Changing Roles

    Some of the most dynamic growth areas for D-Histidine lie in emerging fields. Bioengineering and synthetic biology labs seek non-proteinogenic amino acids to design new metabolic pathways. Pharmaceutical research shifts toward more stable peptide drugs that sidestep rapid breakdown in the body. Startups experimenting with microbially derived enzymes look for reliable chiral building blocks. D-Histidine has moved up the wish list—not as a bulk reagent, but as a known, trusted building unit.

    To answer these new demands, we have added more flexible packaging, expanded data reporting, and tied our analytical QC more explicitly to client regulatory requirements. We work directly with researchers who require supplementary data on side-product formation or atypical impurity patterns. Rather than forcing customers into set ordering patterns, we remain responsive to shifting market needs and the evolving requirements of technical teams at the frontier of science.

    Final Reflections on Supplying D-Histidine

    Producing D-Histidine at scale has taught us that standing behind a product takes more than a tidy label or an export certificate. The small details—batch records, moisture profiles, cross-contamination checks—have become our regular routine because dependable performance supports research and innovation. Lab teams remember deliveries that save their work; production managers value supply partners with transparent records and real-time support.

    Each year brings new analytical tools, tighter standards, and even higher expectations for reproducibility in research and manufacturing. D-Histidine stands as both a technical challenge and an opportunity to help advance fields that rely on sharp analytical results and molecular predictability. We keep pushing to improve, because the real test of a manufacturer is not just in what ships out the door, but in the results it delivers for the chemists, biologists, and engineers moving their fields forward.